BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 33687886)

  • 41. Curcumin induces apoptosis in pancreatic cancer cells through the induction of forkhead box O1 and inhibition of the PI3K/Akt pathway.
    Zhao Z; Li C; Xi H; Gao Y; Xu D
    Mol Med Rep; 2015 Oct; 12(4):5415-22. PubMed ID: 26166196
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Nanoformulation of a Novel Pyrano[2,3-c] Pyrazole Heterocyclic Compound AMDPC Exhibits Anti-Cancer Activity via Blocking the Cell Cycle through a
    Sun X; Zhang L; Gao M; Que X; Zhou C; Zhu D; Cai Y
    Molecules; 2019 Feb; 24(3):. PubMed ID: 30754632
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Selective anticancer activity of hydroxyapatite/chitosan-poly(d,l)-lactide-co-glycolide particles loaded with an androstane-based cancer inhibitor.
    Ignjatović NL; Penov-Gaši KM; Wu VM; Ajduković JJ; Kojić VV; Vasiljević-Radović D; Kuzmanović M; Uskoković V; Uskoković DP
    Colloids Surf B Biointerfaces; 2016 Dec; 148():629-639. PubMed ID: 27694053
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antiproliferative, antioxidant and anti-inflammatory effects of hydroxytyrosol on human hepatoma HepG2 and Hep3B cell lines.
    Tutino V; Caruso MG; Messa C; Perri E; Notarnicola M
    Anticancer Res; 2012 Dec; 32(12):5371-7. PubMed ID: 23225439
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Poly(D,L-lactide-co-glycolide) nanoparticles encapsulated fluorescent isothiocyanate and paclitaxol: preparation, release kinetics and anticancer effect.
    Yang H; Li K; Liu Y; Liu Z; Miyoshi H
    J Nanosci Nanotechnol; 2009 Jan; 9(1):282-7. PubMed ID: 19441308
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Olive Biophenols Oleuropein and Hydroxytyrosol Selectively Reduce Proliferation, Influence the Cell Cycle, and Induce Apoptosis in Pancreatic Cancer Cells.
    Goldsmith CD; Bond DR; Jankowski H; Weidenhofer J; Stathopoulos CE; Roach PD; Scarlett CJ
    Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 30004416
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hydroxytyrosol and the Colonic Metabolites Derived from Virgin Olive Oil Intake Induce Cell Cycle Arrest and Apoptosis in Colon Cancer Cells.
    López de Las Hazas MC; Piñol C; Macià A; Motilva MJ
    J Agric Food Chem; 2017 Aug; 65(31):6467-6476. PubMed ID: 28071050
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Imaging and Chemotherapeutic Comparisons of Iron Oxide Nanoparticles Chemically and Physically Coated with Poly(ethylene glycol)-b-Poly(ε-caprolactone)-g-Poly(acrylic acid).
    Chen GJ; Hsu C; Ke JH; Wang LF
    J Biomed Nanotechnol; 2015 Jun; 11(6):951-63. PubMed ID: 26353585
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cyclin D1 degradation and p21 induction contribute to growth inhibition of colorectal cancer cells induced by epigallocatechin-3-gallate.
    Zhang X; Min KW; Wimalasena J; Baek SJ
    J Cancer Res Clin Oncol; 2012 Dec; 138(12):2051-60. PubMed ID: 22814742
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Protective effects of hydroxytyrosol-supplemented refined olive oil in animal models of acute inflammation and rheumatoid arthritis.
    Silva S; Sepodes B; Rocha J; Direito R; Fernandes A; Brites D; Freitas M; Fernandes E; Bronze MR; Figueira ME
    J Nutr Biochem; 2015 Apr; 26(4):360-8. PubMed ID: 25620693
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The Impact of Olive Oil Compounds on the Metabolic Reprogramming of Cutaneous Melanoma Cell Models.
    Brito C; Tomás A; Silva S; Bronze MR; Serra AT; Pojo M
    Molecules; 2021 Jan; 26(2):. PubMed ID: 33430068
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Selective cytotoxic activity of new lipophilic hydroxytyrosol alkyl ether derivatives.
    Calderón-Montaño JM; Madrona A; Burgos-Morón E; Orta ML; Mateos S; Espartero JL; López-Lázaro M
    J Agric Food Chem; 2013 May; 61(21):5046-53. PubMed ID: 23638972
    [TBL] [Abstract][Full Text] [Related]  

  • 53. CS/PAA@TPGS/PLGA nanoparticles with intracellular pH-sensitive sequential release for delivering drug to the nucleus of MDR cells.
    Wang YY; Zhang DD; Kong YY; Shao LL; Zhang FY; Gao Y; Mu X; Wang J; Li HF; Yu SQ; Xu Q
    Colloids Surf B Biointerfaces; 2016 Sep; 145():716-727. PubMed ID: 27289313
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparative evaluation of antibacterial activity of caffeic acid phenethyl ester and PLGA nanoparticle formulation by different methods.
    Arasoglu T; Derman S; Mansuroglu B
    Nanotechnology; 2016 Jan; 27(2):025103. PubMed ID: 26629915
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Oleil Hydroxytyrosol (HTOL) Exerts Anti-Myeloma Activity by Antagonizing Key Survival Pathways in Malignant Plasma Cells.
    Todoerti K; Gallo Cantafio ME; Oliverio M; Juli G; Rocca C; Citraro R; Tassone P; Procopio A; De Sarro G; Neri A; Viglietto G; Amodio N
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769070
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hydroxytyrosol rich extract from olive leaves modulates cell cycle progression in MCF-7 human breast cancer cells.
    Bouallagui Z; Han J; Isoda H; Sayadi S
    Food Chem Toxicol; 2011 Jan; 49(1):179-84. PubMed ID: 20955751
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Simvastatin induces G
    Chen MJ; Cheng AC; Lee MF; Hsu YC
    J Cell Physiol; 2018 Jun; 233(6):4618-4625. PubMed ID: 28833099
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dexamethasone simulates the anticancer effect of nano-formulated paclitaxel in breast cancer cells.
    Diab T; AlKafaas SS; Shalaby TI; Hessien M
    Bioorg Chem; 2020 Jun; 99():103792. PubMed ID: 32240873
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Novel molecular anti-colorectalcancer conjugate:chlorambucil-adipic acid dihydrizide-glutamine.
    Tabasi MA; Amanlou M; Siadat SD; Nourmohammadi Z; Omoomi FD; Ebrahimi SE; Aghasadeghi MR; Rahimi P; Pourhosseini S; Mehravi B; Ardestani MS
    Anticancer Agents Med Chem; 2013 Nov; 13(9):1449-59. PubMed ID: 23343080
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hydroxytyrosol-Derived Compounds: A Basis for the Creation of New Pharmacological Agents for Cancer Prevention and Therapy.
    Bernini R; Gilardini Montani MS; Merendino N; Romani A; Velotti F
    J Med Chem; 2015 Dec; 58(23):9089-107. PubMed ID: 26225717
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.